Neuroinflammation drives the progression of neurodegenerative disorders like Alzheimer's, Parkinson's, and multiple sclerosis ...
Officials at Qubit Pharmaceuticals report that the company has drastically reduced the number of qubits needed to compute the properties of small molecules with its Hyperion-1 emulator, a device that ...
Pharmaceutical Technology on MSN
RNA-targeting small molecules: a new frontier of drug discovery
With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.
Traditional approaches to drug development face trade-offs. Small molecules are cell permeable and easy to manufacture, but they often suffer from poor specificity and off-target effects. Antibodies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results